Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCB-2019 Booster Study in Adults Primed with ChAdOx1-S or CoronaVac
NCT05087368Phase 2Unknown
- Sponsor
- Instituto D’Or de Pesquisa e Ensino
- Start
- Dec 2021
- Primary completion
- Apr 2022
- Modality
- Recombinant Proteins and Enzymes, Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of SCB-2019 in coronavirus disease 2019 (COVID-19), sponsored by Instituto D’Or de Pesquisa e Ensino. Status: unknown.
02
Drugs
SCB-2019
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05087368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05087368.